Trexquant Investment LP Precision Biosciences Inc Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$9.18 - $14.15 $224,496 - $346,038	-24,455 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$8.07 - $12.52 $197,351 - $306,176	24,455 New	24,455 $306,000
Q3 2020 Nov 06, 2020	SELL	$4.65 - $8.73 $98,105 - $184,185	-21,098 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$4.66 - $8.7 $7,726 - $14,424	1,658 Added 8.53%	21,098 $176,000
Q1 2020 May 08, 2020	BUY	$5.05 - $15.01 $98,172 - $291,794	19,440 New	19,440 $117,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $553M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.